Market Overview

Biomet Hip Lawsuit News: New Order Pertaining to Biomet Hip Settlement Issued in Federal Litigation, Bernstein Liebhard LLP Reports


The Firm is representing numerous Biomet hip replacement clients who may be eligible to participate in the Biomet hip settlement.

New York, New York (PRWEB) April 05, 2014

A new order pertaining to the recently-announced Biomet hip settlement ( has been issued in the U.S. District Court, Northern District of Indiana, where hundreds of claims involving the Biomet M2a Hip Replacement System have been consolidated, Bernstein Liebhard LLP reports. According to the April 2nd Order, the Court has established a secure website for plaintiffs' counsel to utilize in categorizing cases eligible for the Biomet hip settlement. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)

“Our Firm is representing numerous Biomet hip replacement clients who may be eligible to participate in this settlement program. We are pleased to see additional progress in this matter,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential legal consultations to individuals who may have been injured by the Biomet M2a Magnum Hip Replacement System.

Biomet Hip Replacement Settlement

Court documents indicate that more than 1,200 Biomet hip lawsuits have been filed in the Northern District of Indiana on behalf of individuals who were allegedly injured by the M2a Magnum Hip Replacement System. Plaintiffs who have filed these lawsuits allege that the metal-on-metal M2a Magnum can shed dangerous amounts of toxic metal ions in patients' tissue and blood stream, resulting in metallosis, chronic pain, loss of mobility and premature failure of the hip. These complications often necessitate removal and replacement of the device, according to the complaints.

According to court documents, the Biomet hip replacement settlement proposal was announced in the Northern District of Indiana on February 3, 2014, and could ultimately resolve hundreds of claims involving the M2a Magnum hip. Under the terms of the settlement, plaintiffs who received one of the affected Biomet hip replacements as part of an initial surgery that was rectified more than 180 days after it was implanted would eligible for a base award of $200,000. To participate in the settlement program, plaintiffs must file their Biomet hip lawsuits no later than April 15, 2014.

Individuals who suffered painful and debilitating complications allegedly due to the Biomet M2a Magnum hip system may be entitled to compensation for their injury-related damages. Find out more about filing a Biomet hip replacement claim by visiting Bernstein Liebhard LLP's website. To arrange for a free case review, call 800-511-5092 to speak with a member of our legal staff.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

For the original version on PRWeb visit:

View Comments and Join the Discussion!